{
  "DOI": "10.1038/sj.ejhg.5201101",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.ejhg.5201101",
  "alternative-id": [
    "BF5201101"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Loukola",
      "given": "Anu",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Chadha",
      "given": "Monica",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Penn",
      "given": "Sharron G",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rank",
      "given": "David",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Conti",
      "given": "David V",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Thompson",
      "given": "Deborah",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cicek",
      "given": "Mine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Love",
      "given": "Brad",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bivolarevic",
      "given": "Vesna",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yang",
      "given": "Qiner",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jiang",
      "given": "Yalin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hanzel",
      "given": "David K",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dains",
      "given": "Katherine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Paris",
      "given": "Pamela L",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Casey",
      "given": "Graham",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Witte",
      "given": "John S",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2003,
        10,
        15
      ]
    ],
    "date-time": "2003-10-15T09:06:35Z",
    "timestamp": 1066208795000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T01:30:23Z",
    "timestamp": 1684373423000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        17
      ]
    ],
    "date-time": "2023-11-17T22:39:36Z",
    "timestamp": 1700260776270
  },
  "is-referenced-by-count": 30,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2003,
        10,
        15
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2004,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2003,
            10,
            15
          ]
        ],
        "date-time": "2003-10-15T00:00:00Z",
        "timestamp": 1066176000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/5201101.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201101",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201101.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "321-332",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2003,
        10,
        15
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2003,
        10,
        15
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0022-5347(01)65588-5",
      "author": "DS Smith",
      "doi-asserted-by": "publisher",
      "first-page": "1366",
      "journal-title": "J Urol",
      "key": "BF5201101_CR1",
      "unstructured": "Smith DS, Bullock AD, Catalona WJ, Herschman JD : Racial differences in a prostate cancer screening study. J Urol 1996; 156: 1366–1369.",
      "volume": "156",
      "year": "1996"
    },
    {
      "DOI": "10.1002/(SICI)1097-0215(20000101)85:1\u003c60::AID-IJC11\u003e3.0.CO;2-B",
      "author": "AW Hsing",
      "doi-asserted-by": "publisher",
      "first-page": "60",
      "journal-title": "Int J Cancer",
      "key": "BF5201101_CR2",
      "unstructured": "Hsing AW, Tsao L, Devesa SS : International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85: 60–67.",
      "volume": "85",
      "year": "2000"
    },
    {
      "author": "DL McLellan",
      "first-page": "895",
      "journal-title": "CMAJ",
      "key": "BF5201101_CR3",
      "unstructured": "McLellan DL, Norman RW : Hereditary aspects of prostate cancer. CMAJ 1995; 153: 895–900.",
      "volume": "153",
      "year": "1995"
    },
    {
      "author": "PJ Neville",
      "key": "BF5201101_CR4",
      "unstructured": "Neville PJ, Casey G, Witte JS : Hereditary prostate cancer and genetic risk; in Klein (ed): Management of Prostate Cancer. New Jersey: Humana Press, Inc., 2003, 2nd edn.",
      "volume-title": "Management of Prostate Cancer",
      "year": "2003"
    },
    {
      "DOI": "10.1038/84808",
      "author": "SV Tavtigian",
      "doi-asserted-by": "publisher",
      "first-page": "172",
      "journal-title": "Nat Genet",
      "key": "BF5201101_CR5",
      "unstructured": "Tavtigian SV, Simard J, Teng DH et al: A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001; 27: 172–180.",
      "volume": "27",
      "year": "2001"
    },
    {
      "DOI": "10.1086/303096",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1014",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201101_CR6",
      "unstructured": "Rebbeck TR, Walker AH, Zeigler-Johnson C et al: Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet 2000; 67: 1014–1019.",
      "volume": "67",
      "year": "2000"
    },
    {
      "author": "BK Suarez",
      "first-page": "4982",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR7",
      "unstructured": "Suarez BK, Gerhard DS, Lin J et al: Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer Res 2001; 61: 4982–4984.",
      "volume": "61",
      "year": "2001"
    },
    {
      "author": "A Rokman",
      "first-page": "6038",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR8",
      "unstructured": "Rokman A, Ikonen T, Mononen N et al: ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res 2001; 61: 6038–6041.",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1086/319502",
      "author": "D Vesprini",
      "doi-asserted-by": "publisher",
      "first-page": "912",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201101_CR9",
      "unstructured": "Vesprini D, Nam RK, Trachtenberg J et al: HPC2 variants and screen-detected prostate cancer. Am J Hum Genet 2001; 68: 912–917.",
      "volume": "68",
      "year": "2001"
    },
    {
      "author": "L Wang",
      "first-page": "6494",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR10",
      "unstructured": "Wang L, McDonnell SK, Elkins DA et al: Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res 2001; 61: 6494–6499.",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1086/319513",
      "author": "J Xu",
      "doi-asserted-by": "publisher",
      "first-page": "901",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201101_CR11",
      "unstructured": "Xu J, Zheng SL, Carpten JD et al: Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet 2001; 68: 901–911.",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng823",
      "author": "J Carpten",
      "doi-asserted-by": "publisher",
      "first-page": "181",
      "journal-title": "Nat Genet",
      "key": "BF5201101_CR12",
      "unstructured": "Carpten J, Nupponen N, Isaacs S et al: Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002; 30: 181–184.",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ng1021",
      "author": "G Casey",
      "doi-asserted-by": "crossref",
      "first-page": "581",
      "journal-title": "Nat Genet",
      "key": "BF5201101_CR13",
      "unstructured": "Casey G, Neville PJ, Plummer SJ et al: RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002; 32: 581–583.",
      "volume": "32",
      "year": "2002"
    },
    {
      "DOI": "10.1086/340450",
      "author": "A Rokman",
      "doi-asserted-by": "publisher",
      "first-page": "1299",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201101_CR14",
      "unstructured": "Rokman A, Ikonen T, Seppala EH et al: Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 2002; 70: 1299–1304.",
      "volume": "70",
      "year": "2002"
    },
    {
      "DOI": "10.1086/341281",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "116",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201101_CR15",
      "unstructured": "Wang L, McDonnell SK, Elkins DA et al: Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002; 71: 116–123.",
      "volume": "71",
      "year": "2002"
    },
    {
      "author": "M Colombel",
      "first-page": "4313",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR16",
      "unstructured": "Colombel M, Olsson CA, Ng PY, Buttyan R : Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 1992; 52: 4313–4319.",
      "volume": "52",
      "year": "1992"
    },
    {
      "author": "S Gupta",
      "first-page": "2115",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR17",
      "unstructured": "Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H : Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 1999; 59: 2115–2120.",
      "volume": "59",
      "year": "1999"
    },
    {
      "DOI": "10.1093/hmg/3.10.1873",
      "author": "AH Carey",
      "doi-asserted-by": "publisher",
      "first-page": "1873",
      "journal-title": "Hum Mol Genet",
      "key": "BF5201101_CR18",
      "unstructured": "Carey AH, Waterworth D, Patel K et al: Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: 1873–1876.",
      "volume": "3",
      "year": "1994"
    },
    {
      "DOI": "10.1016/0003-9861(91)90602-F",
      "author": "DJ Waxman",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Arch Biochem Biophys",
      "key": "BF5201101_CR19",
      "unstructured": "Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K : Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys 1991; 290: 160–166.",
      "volume": "290",
      "year": "1991"
    },
    {
      "author": "N Makridakis",
      "first-page": "1020",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR20",
      "unstructured": "Makridakis N, Ross RK, Pike MC et al: A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res 1997; 57: 1020–1022.",
      "volume": "57",
      "year": "1997"
    },
    {
      "DOI": "10.1093/jnci/90.16.1225",
      "author": "TR Rebbeck",
      "doi-asserted-by": "publisher",
      "first-page": "1225",
      "journal-title": "J Nat Cancer Inst",
      "key": "BF5201101_CR21",
      "unstructured": "Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB : Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Nat Cancer Inst 1998; 90: 1225–1229.",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1093/carcin/20.9.1727",
      "author": "RM Lunn",
      "doi-asserted-by": "publisher",
      "first-page": "1727",
      "journal-title": "Carcinogenetics",
      "key": "BF5201101_CR22",
      "unstructured": "Lunn RM, Bell DA, Mohler JL, Taylor JA : Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenetics 1999; 20: 1727–1731.",
      "volume": "20",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0140-6736(98)11282-5",
      "author": "NM Makridakis",
      "doi-asserted-by": "publisher",
      "first-page": "975",
      "journal-title": "Lancet",
      "key": "BF5201101_CR23",
      "unstructured": "Makridakis NM, Ross RK, Pike MC et al: Association of missense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet 1999; 354: 975–978.",
      "volume": "354",
      "year": "1999"
    },
    {
      "author": "PL Paris",
      "first-page": "901",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201101_CR24",
      "unstructured": "Paris PL, Kupelian PA, Hall JM et al: Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol Biomarkers Prev 1999; 8: 901–905.",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1097/00008571-199910000-00010",
      "author": "M Wadelius",
      "doi-asserted-by": "crossref",
      "first-page": "635",
      "journal-title": "Pharmacogenetics",
      "key": "BF5201101_CR25",
      "unstructured": "Wadelius M, Andersson AO, Johansson JE, Wadelius C, Rane E : Prostate cancer associated with CYP17 genotype. Pharmacogenetics 1999; 9: 635–639.",
      "volume": "9",
      "year": "1999"
    },
    {
      "DOI": "10.1002/1097-0215(20000801)87:3\u003c434::AID-IJC19\u003e3.0.CO;2-G",
      "author": "A Gsur",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "Int J Cancer",
      "key": "BF5201101_CR26",
      "unstructured": "Gsur A, Bernhofer G, Hinteregger S et al: A polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 2000; 87: 434–437.",
      "volume": "87",
      "year": "2000"
    },
    {
      "author": "T Habuchi",
      "first-page": "5710",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR27",
      "unstructured": "Habuchi T, Liqing Z, Suzuki T et al: Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Cancer Res 2000; 60: 5710–5713.",
      "volume": "60",
      "year": "2000"
    },
    {
      "author": "JM Jaffe",
      "first-page": "1626",
      "journal-title": "Cancer Res",
      "key": "BF5201101_CR28",
      "unstructured": "Jaffe JM, Malkowicz SB, Walker AH et al: Association of SRD5A2 genotype and pathological characteristics of prostate tumors. Cancer Res 2000; 60: 1626–1630.",
      "volume": "60",
      "year": "2000"
    },
    {
      "author": "RA Kittles",
      "first-page": "943",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201101_CR29",
      "unstructured": "Kittles RA, Panguluri RK, Chen W et al: CYP17 promoter variant associated with prostate cancer aggressiveness in African Americans. Cancer Epidemiol Biomarkers Prev 2001; 10: 943–947.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0090-4295(00)00928-6",
      "author": "RK Nam",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "journal-title": "Urology",
      "key": "BF5201101_CR30",
      "unstructured": "Nam RK, Toi A, Vesprini D et al: V89L polymorphism of type-2,5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology 2001; 57: 199–204.",
      "volume": "57",
      "year": "2001"
    },
    {
      "author": "JL Stanford",
      "first-page": "243",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201101_CR31",
      "unstructured": "Stanford JL, Noonan EA, Iwasaki L et al: A polymorphism in the CYP17 gene and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 243–247.",
      "volume": "11",
      "year": "2002"
    },
    {
      "DOI": "10.1101/gr.8.12.1229",
      "author": "FS Collins",
      "doi-asserted-by": "publisher",
      "first-page": "1229",
      "journal-title": "Genome Res",
      "key": "BF5201101_CR32",
      "unstructured": "Collins FS, Brooks LD, Chakravarti A : A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998; 8: 1229–1231.",
      "volume": "8",
      "year": "1998"
    },
    {
      "DOI": "10.1086/319501",
      "author": "M Stephens",
      "doi-asserted-by": "publisher",
      "first-page": "978",
      "journal-title": "Am J Hum Genet",
      "key": "BF5201101_CR33",
      "unstructured": "Stephens M, Smith NJ, Donnelly P : A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.",
      "volume": "68",
      "year": "2001"
    },
    {
      "author": "NE Breslow",
      "first-page": "5",
      "journal-title": "IARC Sci Publ",
      "key": "BF5201101_CR34",
      "unstructured": "Breslow NE, Day NE : Statistical methods in cancer research. Vol I – The analysis of case–control studies. IARC Sci Publ 1980; 32: 5–338.",
      "volume": "32",
      "year": "1980"
    },
    {
      "DOI": "10.1001/archpedi.155.9.1022",
      "author": "M Herman-Giddens",
      "doi-asserted-by": "publisher",
      "first-page": "1022",
      "journal-title": "Arch Pediatr Adolescent Med",
      "key": "BF5201101_CR35",
      "unstructured": "Herman-Giddens M, Wang L, Koch G : Secondary sexual characteristics in boys: estimates from the national health and nutrition examination survey III, 1988–1994. Arch Pediatr Adolescent Med 2001; 155: 1022–1028.",
      "volume": "155",
      "year": "2001"
    },
    {
      "author": "R Ross",
      "first-page": "45",
      "journal-title": "J Natl Cancer Inst",
      "key": "BF5201101_CR36",
      "unstructured": "Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B : Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986; 76: 45–48.",
      "volume": "76",
      "year": "1986"
    },
    {
      "DOI": "10.1002/1097-0215(20011120)95:6\u003c354::AID-IJC1062\u003e3.0.CO;2-3",
      "author": "B Chang",
      "doi-asserted-by": "publisher",
      "first-page": "354",
      "journal-title": "Int J Cancer",
      "key": "BF5201101_CR37",
      "unstructured": "Chang B, Zheng SL, Isaacs SD et al: Linkage and association of CYP17 in hereditary and sporadic prostate cancer. Int J Cancer 2001; 95: 354–359.",
      "volume": "95",
      "year": "2001"
    },
    {
      "author": "CA Haiman",
      "first-page": "743",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201101_CR38",
      "unstructured": "Haiman CA, Stampfer MJ, Giovannucci E et al: The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 743–748.",
      "volume": "10",
      "year": "2001"
    },
    {
      "author": "C Ntais",
      "first-page": "120",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201101_CR39",
      "unstructured": "Ntais C, Polycarpou A, Ioannidis JP : Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003; 12: 120–126.",
      "volume": "12",
      "year": "2003"
    },
    {
      "author": "SJ Plummer",
      "first-page": "928",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201101_CR40",
      "unstructured": "Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS : CYP3A4 and CYP3A5 genotypes, haplotypes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 928–932.",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1093/oxfordjournals.aje.a113948",
      "author": "JH Lubin",
      "doi-asserted-by": "publisher",
      "first-page": "791",
      "journal-title": "Am J Epidemiol",
      "key": "BF5201101_CR41",
      "unstructured": "Lubin JH, Hartge P : Excluding controls: misapplications in case–control studies. Am J Epidemiol 1984; 120: 791–793.",
      "volume": "120",
      "year": "1984"
    },
    {
      "DOI": "10.1093/oxfordjournals.aje.a010051",
      "author": "C Poole",
      "doi-asserted-by": "publisher",
      "first-page": "547",
      "journal-title": "Am J Epidemiol",
      "key": "BF5201101_CR42",
      "unstructured": "Poole C : Controls who experienced hypothetical causal intermediates should not be excluded from case–control studies. Am J Epidemiol 1999; 150: 547–551.",
      "volume": "150",
      "year": "1999"
    },
    {
      "author": "DC Thomas",
      "first-page": "505",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201101_CR43",
      "unstructured": "Thomas DC, Witte JS : Population stratification: a problem for case–control studies of candidate gene associations? Cancer Epidemiol Biomarkers Prev 2002; 11: 505–512.",
      "volume": "11",
      "year": "2002"
    }
  ],
  "reference-count": 43,
  "references-count": 43,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/5201101"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2"
  ],
  "type": "journal-article",
  "volume": "12"
}